meclofenamic acid has been researched along with Focal Segmental Glomerulosclerosis in 1 studies
Meclofenamic Acid: A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
meclofenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Torres, VE | 1 |
| Velosa, JA | 1 |
| Holley, KE | 1 |
| Frohnert, PP | 1 |
| Zincke, H | 1 |
| Sterioff, S | 1 |
1 other study available for meclofenamic acid and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Meclofenamate treatment of recurrent idiopathic nephrotic syndrome with focal segmental glomerulosclerosis after renal transplantation.
Topics: Adult; Creatinine; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Humans; Kidney Transplan | 1984 |